The performance of companies tied to blockbuster drugs like Viagra presents a complex investment picture. While the initial surge of copyright, fueled by Viagra's unprecedented popularity, generated substantial wealth , the patent expiration in key markets has introduced significant uncertainty . Investors are now facing the effect of rival medicat